Evidence map›Paper›PMID 25245112›Full record

ArticleImmunology and cell biology2015

FoxO3 is a negative regulator of primary CD8+ T-cell expansion but not of memory formation.

Susan Togher, Alexandre Larange, Stephen P Schoenberger, Sonia Feau

Open access · greenAbstract read
In one paragraph

Article in Immunology and cell biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Oxidative medicine and cellular longevity · 2021
    Article
  4. Proliferation and Apoptosis of B-Cell Lymphoma Cells under Targeted Regulation of FOXO3 by miR-155.Mediterranean journal of hematology and infectious diseases · 2020
    Article
  5. Article
  6. FOXOs in cancer immunity: Knowns and unknowns.Seminars in cancer biology · 2018
    Review
  7. Review
  8. Akt signaling is critical for memory CD8Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  9. FOXO3 is differentially required for CD8Immunology and cell biology · 2016
    Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Susan TogherDivision of Developmental Immunology, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA.
Alexandre LarangeDivision of Developmental Immunology, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA.
Stephen P SchoenbergerDivision of Developmental Immunology, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA.
Sonia FeauDivision of Developmental Immunology, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA.
La Jolla Institute for Immunology · US

Funding

Targeting HIV Reservoirs in vitro and in vivoR01AI070010 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ZACK, JEROME A. · 2006 to 2014
$3.7M
Cellular and Molecular Regulation of CD8+ T cell memoryR01AI107010 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI SCHOENBERGER, STEPHEN PHILIP · 2013 to 2017
$2.2M
NIAID NIH HHS AI070010NIAID NIH HHS R01 AI070010NIAID NIH HHS R01 AI107010
6 · The paper itself

Abstract

The generation of CD8(+) T cells by vaccination represents an important goal for protective immunity to infectious pathogens. It is thus of utmost importance to understand the mechanisms involved in the generation of optimal CD8(+) T-cell responses. The forkhead box O (FoxO) family of transcription factors has a crucial role in cellular responses to environmental change. Among them, FoxO3 is critically involved in the regulation of cellular proliferation, apoptosis, metabolism and stress resistance to withdrawal of nutrients or cytokine growth factors. Since the role of FoxO3 has been poorly studied in the immune system, here we have evaluated its involvement in the CD8(+) T-cell response. We observe that CD8(+) T cells deficient for FoxO3 undergo a significantly greater primary expansion than their wild-type (WT) counterparts in response to both infectious (vaccinia virus) or non-infectious (non-replicating cellular vaccine) immunogens, resulting in a larger cohort of cells following contraction. These survivors, however, do not undergo a greater secondary response than WT. Taken together, our data show that FoxO3 is a negative regulator of the CD8(+) T-cell response, specifically during the primary expansion.

Indexed as

Immunologic MemoryAnimalsCD8-Positive T-LymphocytesCell DifferentiationCell ProliferationCytokinesForkhead Box Protein O3Forkhead Transcription FactorsLymphocyte CountMice, Inbred C57BLCytokinesForkhead Box Protein O3Forkhead Transcription FactorsFoxO3 protein, mouse

Identifiers

PMID25245112
PMCPMC4324096
OpenAlexW2069660145

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.